Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas H Marx

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Histopathology|April 30, 2015
Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancerNathaniel Melling, Ronald Simon, Martina Mirlacher, et al.
International Journal of Clinical and Experimental Pathology|September 5, 2015
High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancerTim Hanke, Nathaniel Melling, Ronald Simon, et al.
The Journal of Surgical Research|August 6, 2011
ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patientsMichael Tachezy, Hilke Zander, Andreas H Marx, et al.
BMC Gastroenterology|February 5, 2015
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancerPhillip Stahl, Carsten Seeschaaf, Patrick Lebok, et al.
Human Pathology|November 10, 2009
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancerMatthias Choschzick, Annette Lebeau, Andreas H Marx, et al.
Experimental and Molecular Pathology|October 2, 2012
Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancerWinfried H Alsdorf, Till S Clauditz, Tobias Hoenig, et al.
PPAR Research|July 30, 2009
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant MelanomaStefanie Meyer, Thomas Vogt, Michael Landthaler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2013
Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett's esophagusMario Anders, Yasmin Lucks, Muhammad Abbas El-Masry, et al.
Gut|January 7, 2014
Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resectionMario Anders, Christina Bähr, Muhammad Abbas El-Masry, et al.
Human Pathology|March 10, 2009
HER-2 amplification is highly homogenous in gastric cancerAndreas H Marx, Lars Tharun, Johanna Muth, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Histopathology|April 30, 2015
Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancerNathaniel Melling, Ronald Simon, Martina Mirlacher, et al.
International Journal of Clinical and Experimental Pathology|September 5, 2015
High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancerTim Hanke, Nathaniel Melling, Ronald Simon, et al.
The Journal of Surgical Research|August 6, 2011
ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patientsMichael Tachezy, Hilke Zander, Andreas H Marx, et al.
BMC Gastroenterology|February 5, 2015
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancerPhillip Stahl, Carsten Seeschaaf, Patrick Lebok, et al.
Human Pathology|November 10, 2009
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancerMatthias Choschzick, Annette Lebeau, Andreas H Marx, et al.
Experimental and Molecular Pathology|October 2, 2012
Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancerWinfried H Alsdorf, Till S Clauditz, Tobias Hoenig, et al.
PPAR Research|July 30, 2009
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant MelanomaStefanie Meyer, Thomas Vogt, Michael Landthaler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2013
Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett's esophagusMario Anders, Yasmin Lucks, Muhammad Abbas El-Masry, et al.
Gut|January 7, 2014
Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resectionMario Anders, Christina Bähr, Muhammad Abbas El-Masry, et al.
Human Pathology|March 10, 2009
HER-2 amplification is highly homogenous in gastric cancerAndreas H Marx, Lars Tharun, Johanna Muth, et al.
Pageof 11